Related Experiment Video

Updated: Aug 21, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Effect of short-term erythropoietin therapy in anemic premature infants

Pamela D Reiter1, Adam A Rosenberg, Robert Valuck

  • 1Department of Pharmacy (P.D.R.), Center for Pediatric Medicine, The Children's Hospital, Denver, CO 80218, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|November 5, 2004
PubMed

Insights

A 10-day course of subcutaneous recombinant human erythropoietin (rHuEpo) plus oral iron effectively improved hematocrit and reticulocyte counts in anemic premature infants. This treatment demonstrated potential for managing anemia in this vulnerable population.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Pharmacology

Background:

  • Anemia of prematurity is common in very low birth weight infants.
  • Current treatments often involve blood transfusions and iron supplementation.
  • Erythropoietin therapy has shown promise in managing anemia in premature infants.

Purpose of the Study:

  • To evaluate the efficacy of a 10-day subcutaneous recombinant human erythropoietin (rHuEpo) regimen combined with oral iron.
  • To compare this regimen against oral iron alone in anemic premature infants during convalescence.
  • To assess key hematological parameters and transfusion needs.

Main Methods:

  • Prospective, randomized trial in a level III neonatal intensive care unit.
  • Inclusion criteria: infants <32 weeks gestational age, hematocrit ≤28%, corrected reticulocyte count ≤5%, and diagnosed with anemia of prematurity.
  • Primary outcomes: hematocrit, corrected reticulocyte count, and red cell transfusion requirements.

Main Results:

  • Sixty infants were randomized (30 per group).
  • The rHuEpo group showed significantly higher post-treatment hematocrit and corrected reticulocyte counts (p<0.001).
  • A trend towards reduced red cell transfusion requirements was observed in the rHuEpo group.

Conclusions:

  • The studied rHuEpo regimen led to acute improvements in hematocrit and reticulocyte counts in convalescent premature infants.
  • While not statistically significant, a trend towards reduced transfusions was noted.
  • The regimen effectively treats anemia in this specific patient population.
Abstract

More Related Videos

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis06:40

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis

Published on: September 9, 2014

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...